| P50 | author | Michael Roach | Q57612419 |
| | William R Kennedy | Q86032962 |
| P2093 | author name string | Jeffrey D Bradley | |
| | Clifford G Robinson | |
| | Prashant Gabani | |
| | Pamela P Samson | |
| | John Nikitas | |
| P2860 | cites work | Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer | Q30421587 |
| | Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups | Q30438068 |
| | Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy | Q30448358 |
| | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 |
| | No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236 | Q33758565 |
| | Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy | Q33887571 |
| | Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall | Q33923262 |
| | Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study | Q36866000 |
| | Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. | Q37607498 |
| | Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications | Q37675308 |
| | Lung Cancer Statistics | Q38669264 |
| | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer | Q38790915 |
| | Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer | Q38825198 |
| | Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion | Q38865136 |
| | Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall | Q39150722 |
| | Surgical Management of Lung Cancer Involving the Chest Wall | Q39211637 |
| | Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies | Q41134625 |
| | Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience | Q41677591 |
| | The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer | Q45185961 |
| | Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes. | Q45987368 |
| | Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall | Q49906433 |
| | Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. | Q51831128 |
| | Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial | Q56523398 |
| | Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer | Q56523407 |
| | Chest wall invasion in non–small cell lung carcinoma: A rationale for en bloc resection | Q60240400 |
| | Extent of chest wall invasion and survival in patients with lung cancer | Q63548390 |
| | Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection | Q70535998 |
| | Radical radiotherapy for early nonsmall cell lung cancer | Q72463886 |
| | Surgical treatment of lung cancer invading the chest wall: results and prognostic factors | Q73769747 |
| | Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection | Q83212645 |
| | Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT) | Q83386090 |
| | Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule | Q89119874 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2019-02-21 | |
| P1433 | published in | Clinical and Translational Radiation Oncology | Q50817416 |
| P1476 | title | Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy | |
| P478 | volume | 16 | |